HCPCS Level II
J9298
Injection, nivolumab and relatlimab-rmbw, 3 mg/1 mg
Codes near J9298
These sit next to J9298 in the CMS Level II file. All J codes
- J9293Injection, mitoxantrone hydrochloride, per 5 mg
- J9294Injection, pemetrexed (hospira), not therapeutically equivalent to j9305, 10 mg
- J9295Injection, necitumumab, 1 mg
- J9296Injection, pemetrexed (accord), not therapeutically equivalent to j9305, 10 mg
- J9297Injection, pemetrexed (sandoz), not therapeutically equivalent to j9305, 10 mg
- J9299Injection, nivolumab, 1 mg
- J9300Injection, gemtuzumab ozogamicin, 5 mg
- J9301Injection, obinutuzumab, 10 mg
- J9302Injection, ofatumumab, 10 mg
- J9303Injection, panitumumab, 10 mg
NDC crosswalk
| NDC | Drug | Labeler | Billable units |
|---|---|---|---|
| 00003-7125-11 | Opdualag | E.R. Squibb & Sons, L.L.C. | 80 |
Source: CMS ASP NDC-HCPCS crosswalk, effective October 1, 2026 through December 31, 2026.